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Abstract
We utilize a multiscale modeling framework to study the effect of shape, size and ligand composition
on the efficacy of binding of a ligand-coated-particle to a substrate functionalized with the target recep-
tors. First, we show how molecular dynamics (MD) along with Steered MD calculations can be used to
accurately parameterize the molecular binding free energy and the effective spring constant for a receptor-
ligand pair. We demonstrate this for two ligands that bind to the α5β1-domain of integrin. Next, we show
how these effective potentials can be used to build computational models at the meso- and continuum-
scales. These models incorporate the molecular nature of the receptor-ligand interactions and yet provide
an inexpensive route to study the multivalent interaction of receptors and ligands through the construc-
tion of Bell potentials customized to the molecular identities. We quantify the binding efficacy of the
ligand-coated-particle in terms of its multivalency, binding free energy landscape and the losses in the
configurational entropies. We show that (i) the binding avidity for particle sizes less than 350 nm is set
by the competition between the enthalpic and entropic contributions while that for sizes above 350 nm is
dominated by the enthalpy of binding, (ii) anisotropic particles display higher multivalent binding com-
pared to spherical particles and (iii) variations in ligand composition can alter binding avidity without
altering the average multivalency. The methods and results presented here have wide applications in the
rational design of functionalized carriers and also in understanding cell adhesion.
Keywords : receptor-ligand binding, targeted drug delivery, multivalency, equilibrium association
constant, binding free energy, configurational entropy
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2 1 INTRODUCTION
1 Introduction
Specific receptor-ligand interactions is a recurring theme in cell biology. A cell utilizes this process to
respond to external cues by switching on or off signaling cascades and gene expression programs, to
govern and mediate its interactions with the cytoskeleton, the extracellular matrix, and also with other
cells and to commit to different cell fates. Receptor-ligand interactions are known to be one of the key
effectors of receptor trafficking in cells and are also used by external particles such as a virus to gain its
entry into the cytoplasm [1]. The principle of selective interactions between a pair of receptor and ligand
has also been exploited in technologies such as targeted medicine and contrast imaging using functional-
ized nanoparticles (NPs) or nanocarriers (NCs) that are used as vehicles for delivery of therapeutic agents
or for selective localization of diagnostic agents [2–4].
Specific receptor-ligand adhesion has been extensively studied in the literature across various spa-
tial and temporal scales [5–8]. At the cellular scale (characteristic length > 1 µm), the formation of
focal adhesions due to the interaction of cell-surface integrins with the extra-cellular-matrix or to ligand
patterned on substrates [9–19] has been a topic of major interest for experimental investigations of cel-
lular adhesion. These studies have been well complemented with theoretical and computational models
at the cellular scale [20–28] that have helped to gain deeper insight into the various physico-chemical
interactions governing cellular adhesion and its role in motility, signaling, metabolism and mechanotrans-
duction. At the mesoscale (characteristic length ∼ 100 nm) , experimental studies have largely focused
on the biodistribution of functionalized NPs, targeted to various cellular adhesion molecules both in vitro
and in vivo, for use as targeted drug delivery systems [29–36]. A number of theoretical and computational
models [37–50] have been developed to address the question of adhesion and super-selective targeting
of functionalized NCs and their uptake into the target cell [51–56]. At the molecular scale (characteristic
length < 20 nm), all atom molecular dynamics simulations have been extensively used to unravel the
molecular mechanisms governing receptor-ligand interactions [57–61] and the interaction of gold and
silver nanoparticles with the surface of a cell [62–65].
It has been well established that the adhesion of functionalized particles with a substrate strongly
primarily depend on their shape, size and surface chemistry [66–69]. The latter is primarily determined
by the specific interactions between the particle surface and the receptors on the substrate, and to a very
small extent is also determined by the non-specific interactions between the particle and substrate. The
“substrate” here can refer to a cell surface in culture, live cells in a tissue, or cells on enhanced tissue
culture scaffolds such as matrices, flasks and stacks [70, 71]. In our earlier studies, we have shown that
the binding affinity of a functionalized NP is jointly determined by the competition between the bind-
ing enthalpy (that enhances binding) and the loss in configurational entropy of the various components
(that inhibits binding) [38, 72]. This feature is particularly pronounced for NCs with characteristic size
in the mesoscale. The primary objective of this article is to develop a comprehensive picture of this phe-
nomenon and delineate the enthalpy dominated regimes from the entropy dominated regimes for particle
binding.
One of the key challenges in developing such a picture is to address the multiscale nature of the
various processes that promote particle adhesion. For example, a spherical particle of radius 50 nm func-
tionalized with ∼ 150 ligands whose radius is ∼ 3 nm is typically used in targeted experiments [42, 73]
for which the surface ligand density is around 14%. This is typical of biomedical applications due to (i)
the large cost of antibodies and (ii) the risk of triggering immune response at higher densities. At such
low ligand densities it is only appropriate to treat the interactions between the ligand on the particle and
receptors on the target substrate as patchy, rather than as a continuum. This would require a different
class of models in which we retain the molecular nature of the receptor-ligand interactions. In the past,
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3researchers have treated NC adhesion either as a continuum [37, 43, 44] or as semi-continuum [38, 48]
to quantify the specific adhesion of functionalized particles with rigid and flexible substrates. A main
ingredient, namely entropy loss of receptors facilitating multivalent binding, is absent in such contin-
uum models, which we address using our approach. Moreover, in all of these works, the framework
for incorporating the molecular identities of the receptor-ligand interactions was primarily determined
from experiments [38]. However, as shown in this work, a computational route to include the molecular
identities can also be achieved using the molecular dynamics framework.
In this article, we utilize a generalizable multiscale computational framework to study the multivalent
adhesion of ligands immobilized on a particle surface with receptors diffusing on a substrate, as displayed
in Fig. 1. Our multiscale approach consists of two steps: (i) molecular scale characterization of mono-
valent receptor-ligand interactions (Fig. 1(a)), and (ii) a mesoscale model for multivalent receptor-ligand
interactions (Fig. 1(b)). Details of the multiscale coupling between the molecular scale and the mesoscale
are described in the methods section. We systematically investigate the role of (i) receptor-ligand inter-
action strength, (ii) particle shape, (iii) particle size and (iv) ligand concentration on the binding avidity
of the NC. In this work, we will only focus on NC adhesion to rigid substrates, while its extension to
flexible substrates is straightforward as shown in our earlier work [48]. However, here, we do provide
a computationally efficient approximation to consider the effect of substrate compliance, such as when
the NC binds a deformable cell membrane in a live cell by building the effect of compliance into the
interacting potential. We quantify the equilibrium bound state of a NC bound to a substrate in terms of
(i) the losses in the configurational entropies and (ii) the gain in binding enthalpy. We explicitly compute
these terms and delineate the entropy-dominated and enthalpy-dominated regimes for NC binding.
0.5 μm
substrate 
functionalized 
with target 
receptors
2a
19  nm
ligand-
coated-
particle
receptor
ligand
(a) molecular scale (b) mesoscale
(c) continuum scale
Figure 1: Multiscale aspects of modeling ligand coated particles binding to a substrate functionalized
with the target receptors. (a) A snapshot of a receptor-ligand interaction at the molecular scale, (b) mul-
tivalent binding of a ligand coated spherical particle – the ligand (arrows) and receptors (cylinders) that
mediate the binding are colored magenta and blue, respectively, and (c) a snapshot of our continuum
scale simulations to estimate binding efficacy.
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Binding energy, ∆Hb (kBT )
System Receptor Ligand sequence EXPERIMENTS AUTODOCK SMD
Strong binder (SB) ICAM-1 anti-ICAM1 (YN1) −19.1 [38] - -
Intermediate binder (IB) α5β1 domain of Integrin KGGEPRGDTYR −11.45 [74] −12.45 −12.22
Weak binder (WB) α5β1 domain of Integrin GERGDGSFFAFRSPF −1.76 [75] −1.82 −1.71
Table 1: SB, IB, and WB, the three receptor-ligand systems used in our study, along with the corre-
sponding binding energies (in kBT ). The experimental values have been taken from the literature while
the computational values are our estimates obtained using Autodock and steered molecular dynamics
(SMD) simulations. The details of these calculations are given in the methods section, and discussions
on the Autodock and SMD results may be found in the results sections.
2 Receptor-ligand pairs of interest
We will focus on three specific receptor-ligands pairs, denoted as (i) strong binder (SB), (ii) intermedi-
ate binder (IB), and (iii) weak binder (WB). The SB system corresponds to an Inter-cellular adhesion
molecule (ICAM aka CD54) receptor interacting with its YN1 antibody, while the IB and WB systems
correspond to the α5β1 domain of integrin interacting with peptide sequences KGGEPRGDTYR and
GERGDGSFFAFRSPF, both of which contain the well-recognized RGD (Arg-Gly-Asp) binding domain.
These sequences are peptidomimetics that mimic the integrin binding domains found in the extracellular
matrix proteins, fibronectin and collagen, respectively [74–77]. The interaction energies of each of these
pairs are listed in Table 1, and the snapshots of the IB and WB systems in their respective bound states
are shown in Suppl. Info., Sec. S1.
Our choice of these pairs of receptors and ligands has been motivated by the fact that : (i) their inter-
action energies represent three different energy scales that spans over the physiologically relevant values
for receptor-ligand interactions (∼ −2, −10 and −20 kBT for WB, IB and SB, respectively, as shown
in Table 1) and (ii) the wide applicability of these results both in the development of functionalized
NCs and also in understanding cell adhesion with its substrate. Since the SB system, that is comprised
of the ICAM1-YN1 receptor-ligand pair, has been previously well characterized [38, 48, 78–80], we
will demonstrate the applicability of our molecular characterization techniques only for the IB and WB
systems. Another benefit of considering SB, IB and WB is that it enables us to account for the phe-
nomenon of opsonization (deposition of albumin or FC receptor fragments from the plasma onto the
NC surface) [66, 67, 81]. In this case, while the functionalized molecule can be modeled as a SB, the
opsonized moieties can be treated either as a IB or WB.
3 Methods
We use a bottom-up approach to self-consistently estimate the binding affinity of a functionalized NC.
In this approach, we first characterize the monovalent interactions of a receptor-ligand pair using molec-
ular dynamics techniques. The molecular scale interaction potentials are then used as an input for the
mesoscale models to estimate the thermodynamic stability of the multivalent receptor-ligand bonds. In
this section, we present the details of the various models and simulations techniques employed in each
of these length scales.
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3.1 Molecular methods and atomistic potentials
(i) Atomistic models for IB and WB systems: The structure of the α5β1 domain of integrin, which is the
receptor for both the IB and WB systems, was extracted from its complex with RGD peptide obtained
from the RSCB Protein Data Bank (pdb id: 3VI4) [60]. The corresponding ligand sequences for the
IB and WB systems were prepared using standard procedures. In our model for the receptor, we also
retained the Ca2+ and Mg2+ ions found to be co-crystallized in the 3VI4 structure. In our simulations we
use standard protocols defined under the AMBER force field to account for the difference between Ca2+
and Mg2+ ions. For non-conventional force fields care should be exercised to make this distinction.
(ii) Docking studies: The binding sites for the IB and WB systems were determined using AutoDock [82],
a genetic algorithm based conformer search tool. The AutoDock search was performed using a 30 A˚ cubic
sampling box, centered on the active site of the integrin headpiece, with a grid size of 0.375 A˚ . The inte-
grin was kept fixed during this procedure and the initial ligand population was set to 200. For each system,
the complex with the highest docking score was taken to be the bound structure of the receptor-ligand
complex and these were used as the initial configuration for their respective molecular dynamics (MD)
simulations.
(iii) MD simulations and generation of equilibrium bound structures: We performed molecular dynamics
simulations of the bound complexes using GROMACS4.6 [83] with the Amber99SB-ILDN protein-
nucleic AMBER94 force field [84] for the organic molecules. The bound complexes were solvated in
SPC/E water [85] in a periodic cubic box of length 70 A˚ . The total number of atoms inclusive of the
complex, counterions, and water were over 400, 000. The equilibrium bound structure for both the IB
and WB systems were obtained by (a) energy minimization in the NVT ensemble followed by (b) equili-
bration in the NPT ensemble at 300 K for 10 ns, with a 2 fs timestep; here the hydrogens were constrained
using the SHAKE algorithm. A representative snapshot of the equilibrium receptor-ligand conformation
for the WB system is shown in Fig. 1(a).
(iv) Steered molecular dynamics (SMD) and Umbrella Sampling: We performed SMD calculations on
the equilibrium bound state structures of the receptor and ligand to compute a representative binding
path for the IB and WB systems. In both cases, the distance between the center of masses of integrin
receptor and its ligand was taken to be the reaction coordinate for the SMD calculations. We performed a
10 ns SMD in the NPT ensemble with a pulling rate of 0.01 nm/ps and a pulling spring constant of 1000
kJ/(mol nm2). We stored the snapshot of the system at every time step and these snapshots were later
used as the starting configuration for the umbrella sampling. In an umbrella sampling simulation, we first
chose 30 different snapshots (sampling windows), each separated by a window size of 0.15 A˚ and added
appropriate center of mass constraints. Next, for each of the snapshots we performed a 2 ns NPT equi-
librium run followed by a 10 ns NPT production run and collected statistics for the reaction coordinate.
The histograms of the reaction coordinate in all the windows were converted to a potential of mean force
using the Weighted Histogram Analysis method (WHAM) [86, 87]. The obtained potential of mean force
was taken to be the atomistic potential for receptor-ligand binding.
3.2 Mesoscale model for multivalent receptor-ligand interactions
We adopt the coarse grained approach developed in earlier works [38, 48, 78, 79] to study the interac-
tion of a ligand-coated NC with cell surface receptors. A snapshot of our mesoscale model is shown in
Figs. 1(b) and (c). In our representation, the NC is modeled as a spheroid with three principle dimensions
a, b and c, with b = c. We define the particle aspect ratio as ε = a/b, such that ε = 1.0 for spherical
particles, ε < 1.0 for oblate spheroids and ε > 1.0 for prolate spheroids. The target substrate is taken
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to be a square, rigid planar surface, of length Ls. We coarse grain each receptor and ligand molecule as
flexible rods of lengths Lr and Ll, respectively; these are shown as cylinders and arrows in Fig. 1(c).
The Nl ligands are uniformly distributed and immobilized on the surface of the NC and are oriented
to be along the local surface normal (see Suppl. Info., Sec. S2 for details). The Nr receptor molecules
are randomly distributed on the planar substrate and are constrained to diffuse only along the xy-plane;
in general, the receptors diffuse on the two dimensional curvilinear manifold defined by the flexible cell
membrane [48]. The total flexural energy of the receptors is given by:
Hflex = 1
2
Nr∑
i=1
Kflex (Lr sin θi)2 . (1)
Kflex is the flexural stiffness of the receptors and θi is the flexure angle for the i th receptor, measured
with respect to the z direction (taken to be the unflexed orientation of the receptors). Since the ligands
are immobilized on the surface of the NC we ignore any contributions due to ligand flexure. In an earlier
work, we showed that the flexural stiffness of the receptor can be calculated using MD simulations [80].
Each ligand on the particle surface interacts with its receptors on the substrate and can form a bond,
as shown in Fig. 1(b); the total number of bonds formed by the functionalized ligands is defined as
the multivalency of the particle. The interaction between a receptor and a ligand is modeled as a Bell
potential [88, 89]:
Hbond =
{
0 when d ≥ d∗
∆Hb + Kb
2
d2 when d < d∗
. (2)
Here, d is the distance between the tips of the receptor and the ligand and d∗ =
√
2∆Hb/Kb is the
cutoff distance above which the receptor and ligand are in an unbound state. ∆Hb is the binding energy
and Kb is the stiffness of the receptor-ligand bond. The values of ∆Hb and Kb for IB and WB systems
are directly determined from the atomistic potentials constructed using molecular dynamics simulations,
which enables a coupling between atomistic scale and mesoscale models.
The total energy of a NC bound to a substrate with m multivalent bonds is then given by:
H =
m∑
i=1
(Hflex(θi) +Hbond(di)) . (3)
Configurational degrees of freedom: The configurational space for the mesoscale adhesion model is
comprised of:
1. The position of the center of mass of the NC, in Cartesian coordinates, Xp = {Xp, Yp, Zp}.
2. The orientation of the NC, in terms of the Euler angles, Θp = {φp, θp, ψp}.
3. The spatial position of all receptors, in Cartesian coordinates, Xr = {{x1, y1} , · · · , {xNr , yNr}}.
4. The orientation of all receptor molecules, Θr = {{θ1, φ1} , · · · , {θNr , φNr}}, in the spherical polar
coordinates.
5. The bonds formed between the receptors and ligands {b}.
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The x and y dimensions are subject to periodic boundary conditions while the boundary along the z
direction is taken to be a hard wall.
Monte Carlo moves to evolve the various degrees of freedom: We evolve the system in its configura-
tional space through a set of five independent Monte Carlo moves. Each move is randomly chosen and is
designed to alter only one degree of freedom while holding the others fixed.
1. Diffusion of the NC: The center of mass of the NC is moved to a new random position Xp + δXp
within a cube of size , centered about Xp. The move is accepted using the Metropolis scheme [90]
according to the probability min (1, exp(−β∆H)) where ∆H is the change in the total energy
(eqn. (3)) due to the change in position and β = ( kBT )
−1. Here kB denotes the Boltzmann constant
and T the absolute temperature.
2. Rotation of the NC about its own axis: The orientation of the NC is changed from
{
φp, θp, ψp
}
to a
random orientation {φp + δφp, θp + δθp, ψp + δψp}, subject to the constraint 0 < φp + δφp < 2pi,
0 < θp + δθp < pi, and 0 < ψp + δψp < 2pi. The new orientation is accepted according to the
Metropolis acceptance scheme. For particles with aspect ratio ε 6= 1, we represent the rotational
degrees of freedom in terms of quaternions [91, 92] and evolve them using a hybrid molecular
dynamics-Monte Carlo scheme, as described in Suppl. Info., Sec. S4.
3. Receptor diffusion on the substrate: The position of a randomly chosen ligand is changed from Xr
to Xr+δXr, where the components of δXr are randomly chosen within a square of size η centered
about Xr. The move is accepted according to the Metropolis scheme.
4. Receptor flexure: The orientation of a randomly chosen ligand i is changed from {θi, φi} →
{θi + δθi, φi + δφi}, where the randomly chosen increments are such that 0 < θi + δθi < pi
and 0 < φi + δφi < 2pi. The move is accepted using the Metropolis scheme.
5. Formation and breakage of receptor-ligand bonds: A bond is formed between a randomly chosen
receptor-ligand pair if they are previously unbound, and the bond is broken/retained (with equal
probability) if the chosen pair is already in the bound state. This move is performed and accepted
by a configurational bias Monte Carlo move using the Rosenbluth sampling technique [93]. The
configurational bias scheme for a chosen receptor i and ligand j is implemented by generating 200
trial orientations for the receptor (where θ and φ are chosen randomly) and 200 random trial bound
states (1 for bound and 0 for unbound). The selected trial orientation is then accepted using the
Metropolis scheme for configurational bias [93].
The parameters  and η are chosen and adjusted during runtime so that half of the attempted moves are
accepted.
Mesoscale interaction potentials: We use umbrella sampling and WHAM to compute the potential of
mean force (PMF) for a NC bound to a planar substrate. In our calculations, we take z-separation between
the planar substrate and the center of mass of the NC as the reaction coordinate. If the planar substrate
is taken to be at z = 0, the reaction coordinate for the PMF calculations is given by Zp. The umbrella
sampling calculations are performed with an additional biasing potential:
Hbias = Kbias
2
(Zp − Zp,0)2 . (4)
Here Zp,0 is the position of the window for which the umbrella sampling is performed and the PMF
is self consistently determined from the histograms of Zp using WHAM [86, 87]. In our calculations, the
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PMF is a direct measure of the absolute free energy for binding since the unbound states (whereH = 0)
and the bound states (whereH 6= 0) are well defined along our choice of the reaction coordinate.
All our studies were performed with a constant ligand density of 14% and a constant receptor density
of 2000 receptors/µm2, as reported in experiments [94, 95]. The dimension of the substrate Ls was taken
to be five times larger than the dimension of the NC (i.e., Ls = 5a for ε ≥ 1 and Ls = 5b for ε < 1). A
typical equilibrium simulation was run for a total of 109 steps which were distributed between moves 1
to 5 at a ratio of 10%, 10%, 10%, 20% and 50%, respectively. The free energy simulations were run for
3 × 108 steps per window with a similar distribution for the different classes of moves. All simulations
were run in quadrupulates for realizing different ensembles and computing statistical errors. The error-
bars in the free energy calculations denote the standard deviation over the four ensembles. The typical
run time for an equilibrium simulation on a 2.6 GHz processor is about 24 hours, while that for each
window in the free energy calculations is 10 hrs.
4 Results
4.1 Characterization of receptor-ligand interactions and parametrization of coarse grained potentials
Computed values of receptor-ligand binding energies compare well with experimental estimates:
We computed the binding free energies (∆Hb) for the IB and WB systems using two different approaches:
(i) docking studies and (ii) SMD calculations, as described in the methods section. It is straightforward
to compute ∆Hb using docking studies: we found ∆Hb = −12.45 and −1.82 kBT for the IB and WB
systems, respectively; while the corresponding values from the SMD calculations were determined as fol-
lows. HSMD, the potential of mean force (PMF) for single receptor-ligand interactions computed using
SMD calculations, for both the IB and WB systems are displayed in Figs. 2(a) and (b), respectively. We
take the binding energy to be equal to the minimum value of the PMF, i.e., ∆Hb = min(HSMD). From
the PMFs in Fig. 2 we estimated ∆Hb = −12.22 kBT for IB and ∆Hb = −1.71 kBT for WB. The
values of ∆Hb computed through the two methods are in excellent agreement with each other and also
with experimentally obtained binding energies [74, 75]; this comparison is displayed in Table 1.
Explicit calculations show that the receptor-ligand interactions follow a Bell potential: The PMFs
shown in Fig. 2, as pointed out earlier, represent the free energy landscape for monovalent receptor-
ligand binding. The computed values of HSMD may then be directly used in place of eqn. (2) to model
the receptor-ligand interactions in our mesoscale model for NC adhesion. In this approach,HSMD should
be resolved at a very high spatial accuracy which leads to increased computational cost. As an alternative,
we approximateHSMD to an analytic function which allows for an equivalent but efficient representation
of the receptor-ligand interactions. Upon closer observation it may be seen that the PMFs for both the
IB and WB systems resemble the Bell potential [88, 89], given by eqn. (2). Others have shown experi-
mentally that the Bell potential is a good representation of SB interactions [38, 96, 97]. Using the values
of ∆Hb determined earlier, we fitted eqn. (2) to the molecular PMFs and the best fit curves for the two
systems are shown as solid lines in Fig. 2. From the fitting procedure, we determined the spring constants
for the IB and WB systems to be Kb = 0.38 and 0.56 N/m, respectively. It should be noted that the com-
puted values of Kb are similar to that for the SB system which was estimated to be 1 N/m using AFM
force spectroscopy [38, 96, 97].
Our multiscale coupling method using the Bell potential, in which we parameterize the receptor-ligand
interaction energy (eqn. (2)) directly using all atom molecular dynamics simulations, is a straightforward
approach to couple the molecular scale information to the mesoscale. In more complex scenarios where
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Figure 2: The molecular potential of mean force (HSMD) for (a) the IB and (b) the WB systems. The
solid lines denote the best fit of the data to a Bell bond potential, see eqn. (2). The values of Kb for the
IB and WB systems are found to be 0.38 N/m and 0.56 N/m, respectively.
the free energy landscape cannot be approximated using simple analytical functions, such as for receptor-
ligand interactions that display a catch-bond like behavior, the PMF can be directly used as a lookup table
in place of Eqn. (2). Methods to define reaction coordinates and estimate free energy landscapes for such
complex systems has been previously demonstrated for a number of biomolecules, see Sotomayor and
Schulten [98] for a review. The effective spring constant Kb may also be estimated by analyzing the
equilibrium trajectories of the bound state of the receptor-ligand, as we discuss below.
Estimating the stiffness of receptor-ligand bonds through principal component analysis (PCA): We
used PCA to analyze 10 ns equilibrium trajectories of the IB and WB systems. For each system the
3N × 3N covariance matrix of atomic positional fluctuations was constructed from the positions of the
N α-carbon atoms (Cα) in the backbone of the receptor-ligand complex. Before constructing the covari-
ance matrix, the overall translations and rotations associated with the center of mass of the protein were
removed by reordering the protein backbone in all successive frames with the first frame. This results in
6 of the 3N eigenvalues to be practically zero. The 3N − 6 eigenvalues (λ1 > · · · > λ3N−6) and the
3N−6 eigendirections (eˆ1, · · · , eˆ3N−6) of the covariance matrix denote the magnitudes and directions of
the 3N−6 collective modes that dominate the equilibrium fluctuations of the bound receptor-ligand pair.
Treating the system as a collection of 3N − 6 independent harmonic oscillators, the effective stiffness
of the nth mode can be computed as ζn = kBT/λn [99]. In Fig. 3(b) the ligand backbone is shown as a
bead-stick representation while the receptor backbone is shown as a ribbon. In our calculations we take
all receptor Cα atoms within 6 nm of any ligand Cα atom to constitute the binding domain of the receptor.
Let r denote the distance between the centers of masses of the receptor binding domain and that of the
ligand. Our aim here is to identify which of the eigenmode(s) project significantly along r.
λn for the first 100 principal modes for the IB and WB systems are shown in the main panels of
Fig. 3(a), while the corresponding values of ζn are shown as insets to Fig. 3(a)—the value of ζn for
n < 200 is in the range 10−4–100 N/m. In both the cases, it may be seen that λn is significant only for
the first 10 modes indicating that the principal dynamics are contained within these modes. Our analysis
of the motion of the IB and WB systems along the first 10 principal modes shows that these modes do
not significantly contribute to fluctuations in r. For instance, the arrows in Fig. 3(b) shows the magnitude
and the direction of the first principal mode which, as may be seen for both the IB and WB systems, only
alters the configuration of the receptor far from the binding site.
We computed the measure |dr| to determine the principal modes that contribute the most to the
observed fluctuations in r. It is defined as the displacement of the individual Cα atoms in the ligand
with respect to the center of mass of the binding domain in the receptor. Fig. 3(c) shows P (|dr|), the
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Figure 3: Principal component analysis (PCA) of 10 ns equilibrium trajectories of the IB and WB sys-
tems. λn, for n = 1 · · · 100, the first 100 eigenvalues of the covariance matrix, are shown in panel (a) and
the corresponding spring constants ζn = kBT/λn are shown in the insets. Panel (b) shows the average
positions of the Cα atoms in the IB and WB systems, and the arrows denote the direction of the first
eigenvector eˆ1. The distribution of the average displacement (|dr|) of the Cα atoms in the ligand are
shown in panel (c), while their projections (|dr · eˆn|) along various eigendirections eˆn are shown in panel
(d).
distribution of |dr|, for both the IB and WB systems. P (|dr|) for the WB shows a wider distribution
compared to the IB and this is attributable to the weaker free energy landscape of the WB system, as
was shown in Fig. 2. Next, the measure |dr| was projected on to each eigenvector as dr · eˆn and the
distributions of the top 6 projections for the IB and WB systems are shown in Fig. 3(d). For the IB, we
find the maximum displacement of the binding region to be in the range 0.1–0.2 nm and distributed along
principal modes with 29 ≤ n ≤ 196. Similarly, for the WB we find the maximum displacements to be in
the range 0.3–0.5 nm and distributed between modes 19 ≤ n ≤ 41. From the values of the force constant
ζn shown in the inset to Fig. 3(a) we estimate the effective stiffness of the receptor-ligand bond in the IB
and WB systems to be in the range Kb = 10−1–100 N/m. Hence, the values of Kb estimated using PCA
agrees very well with the values estimated previously using Steered MD calculations.
4.2 Effect of substrate compliance
The local mechanical micro-environment, which denotes the compliance of the substrate on which the
target receptor molecule is expressed, is also an important factor that influences NC binding. For example,
a cell membrane, a PDMA substrate and a glass surface are examples of substrates with high, nominal
and zero compliance, respectively. This can further be quantified by expressing the inverse of the sub-
strate compliance in terms of the substrate’s bending rigidity κ = Y h3/12, where Y is the Young’s
modulus and h is the substrate thickness. On this scale, receptors in their natural environment (i.e., on
a cell membrane) feel a substrate with bending rigidities in the range 20–160 kBT , while those immo-
bilized on a glass substrate feel a bending rigidity of ∼ 1018 kBT . We have previously developed an
explicit model to study the effect of membrane compliance on nanocarrier binding [48]. In this work, we
account for the effect of the substrate compliance on NC binding using a mean field approach, which is
computationally much more tractable than the rigorous approach in [48]. While this implementation is
new, it was inspired by a similar discussion by Mogilner and Oster [100]. We outline this approach next.
Biophysical Journal 00(00) 1–28
4.3 Results from the mesoscale simulations 11
Consider two neighboring receptor molecules at a distance 2x apart on a substrate. In our calculations,
we only account for the bending modes of the substrate and neglect any contributions due to stretching
— this is a very good approximation even for highly compliant substrates such as cell membranes. The
maximum radius of curvature that can be induced by independent deformations of the receptor molecules
is x, for which the membrane bending energy is 4piκ assuming that the deformation is hemispherical in
shape. A harmonic approximation to model this deformation can be constructed by satisfying the con-
dition 4piκ = Kmx2/2, where x is the maximum extent of deformation normal to the planar membrane.
This yield the spring constant for membrane compliance as Km = 8piκ/x2. Setting x ∼ 5–10 nm, equal
to the average distance of separation between the receptors on the surface, we estimate Km to be in the
range 10−2–10−3 N/m. In effect, we are accounting for the energy of substrate deformation as an inde-
pendent additional contribution resulting from receptor-ligand interactions. In this mean field approach,
we model a receptor-ligand bond as two springs in series — the first spring corresponds to the explicit
interaction between the receptor and ligand with a spring constant Kb and the second spring corresponds
to the fluctuations in the substrate with a spring constant Km. The effective spring constant, that includes
the effect of substrate compliance, is then given by Keffb = KbKm/(Kb +Km), and its value in our calcu-
lations is in the range 10−3–100 N/m. In the following, we represent the interactions between a receptor
and ligand in the mesoscale model using a modified form of eqn. (2) given by:
Hbond =
 0 when d ≥ d
∗
∆Hb + K
eff
b
2
d2 when d < d∗
, (5)
with d∗ =
√
2∆Hb/Keffb .
4.3 Results from the mesoscale simulations
We first present a brief overview of the statistical mechanics framework to evaluate the binding avidity
of a functionalized NC – see [38, 48] for the complete derivation. The equilibrium association constant
for a bound NC is given by:
Ka =
1
[L]
Pb
Pu , (6)
where [L] is the ligand concentration. The probability for one NC to be in an unbound state is given by:
Pu = 1Z
Nr∏
i=1
∫
u
dXr,i
∫
u
dΘr,ie
−βHflex
∫
u
dXp
∫
u
dΘp, (7)
where u implies that the integral is carried over all configurational degrees of freedom in which the NC
is in an unbound state. Z is total partition function that accounts for both the unbound and bound states.
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The probability for the NC to be in a bound state with exactly m multivalent bonds is given by:
Pb = 1Z
Nr−m∏
i=m+1
∫
u
dXr,i
∫
u
dΘr,ie
−βHflex

m∏
j=1
∫
b
dXr,j
∫
b
dΘr,je
−βHflex

∫
b
dXp
∫
b
dΘp exp(−βWNC). (8)
Here b denotes the region of the configurational space corresponding to the bound state of the NC and
WNC is the free energy of binding, computed using umbrella sampling and WHAM as described in
the methods section. Using eqns. (7) and (8) in eqn. (6), and taking [L] = (
∫
u
dXp)
−1, the association
constant may be computed as [38]:
Ka =
(
Nr !
(Nr − 〈m〉) ! 〈m〉 !
)(
Nl
〈m〉
)
(T1)〈m〉(T2)〈m〉 (T3) (T4). (9)
Here, we take 〈m〉 as the average multivalency in the lowest free energy state and the first term denotes a
binomial distribution to select 〈m〉 receptors out of Nr. The association constant, in addition to the first
two terms which arise from combinatorial entropy, is a product of four additional terms namely:
(i) T1 =
∫
b
dx1dy1/
∫
u
dx1dy1, the translational entropy of bound and unbound receptors,
(ii) T2 =
∫
b
sin θ1dθ1e
−βHflex/
∫
u
sin θ1dθ1e
−βHflex , the flexural entropy of bound and unbound receptors,
(iii) T3 = σφpσcos θpσψp/8pi2, the rotational entropy of bound and unbound NC and
(iv) T4 =
∫
b
(dXpdYp)
∫
b
dZp e
−βWNC , the enthalpic contribution due to energy gain upon binding.
These four terms can directly be computed from our mesoscale simulations and the various symbols
represent the different configurational degrees of freedom, defined in the methods section. σφp and σψp
are the rms fluctuations in the Euler angles φp and ψp and σcos θp is the rms fluctuations in the cosine of
θp [101]. Ka is determined by both the entropic loss and enthalpic gain due to binding, and it should also
be noted that the entropic contributions start to dominate as the multivalency 〈m〉 increases. In comput-
ing T1, we take the unbound area for the receptor
∫
u
dx1dy1 = L
2
s/Nr, i.e., equal to the average area per
receptor [38, 48]. In the following, we will show how the multivalency, the free energy of binding and
the various entropic terms (T1–T3) vary with respect to variations in the system parameters.
Effect of binding free energy and spring constant on multivalent binding of spherical NCs: We
compare the equilibrium profiles for the SB, IB and WB systems for a NC with a = b = c = 50 nm
binding to a functionalized flat substrate. We chose the surface density of the functionalized ligands to be
14%, which fixes the number of ligands on the NC to beNab = 162. We first study how the energy barrier
Biophysical Journal 00(00) 1–28
4.3 Results from the mesoscale simulations 13
∆Hb and the effective spring constant Keffb influence NC binding. The multivalency distribution P (m),
the localization profile of the bound receptors and the free energy of bindingWNC for three different val-
ues of ∆Hb (chosen to represent the SB, IB and WB systems) and four different values ofKeffb (chosen to
represent the range of spring constants determined above) are shown in Fig. 4. The left, middle and right
panels correspond to the SB, IB and WB systems, respectively, while curves marked 1 , 2 , 3 and 4
correspond to Keffb = 1, 10−1, 10−2 and 10−3 N/m, respectively.
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Figure 4: Equilibrium statistics for a 100 nm NC bound to a substrate functionalized with SB , IB and
WB systems. The four sets of data in each panel, marked 1 , 2 , 3 and 4 correspond to Keffb = 1,
10−1, 10−2 and 10−3 N/m, respectively. Panels (a)-(c) show P (m), the probability density of the NC
multivalency m. Panels (d)-(f) show the localization density for the x and y positions of the bound recep-
tors measured with respect to the center of mass of the NC, and the NC boundary is marked as solid
lines. Panels (g)-(i) show the potential of mean force (PMF) as a function of the z position of the NC.
The PMFs are truncated at 65 nm which is the distance of minimum approach between the NC and the
substrate.
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P (m), the probability distribution for the system to have m multivalent bonds, shows a strong depen-
dence on ∆Hb and Keffb , as may be seen in Figs. 4(a), (b) and (c). For a given value of Keffb , as expected,
the SB system shows a higher multivalent binding. For all the three systems the number of multivalent
bonds increases as the stiffness of the receptor ligand bonds decreases: e.g. in Fig. 4(a), we observe a
peak multivalency of m ∼ 5 for Keffb = 1 N/m which increases to m ∼ 25 for Keffb = 10−3 N/m.
We observe the SB system to always be in a bound state for all values of Keffb ; this is characterized by
P (m = 0) = 0.0 for all panels in Fig. 4(a), while the binding statistics for the IB and WB systems
are strongly dependent on Keffb . The IB system is observed to be fully bound only when Keffb ≤ 10−2
N/m (see Fig. 4(b)), while the WB system remains primarily in an unbound state for all values of Keffb
as shown in Fig. 4(c). These results demonstrate the fact the binding behavior of a functionalized NC
depends on both the strength and stiffness of the receptor-ligand bond.
The dark spots in the colormaps shown in Figs. 4(d), (e) and (f) denote the positional projection to
the xy-plane of the tip of the bound receptors with respect to that of the center of mass of the NC. The
projection of the NC boundary including the size of the functionalized ligands are shown as solid circles.
For all systems studied here, the localization pattern of the bound receptors is influenced by both ∆Hb
and Keffb . Ligands bound to NCs with higher multivalency, (e.g. the SB in Fig. 4(d)), display annulus-like
patterns whose density increases with increasing multivalency. In contrast, NCs that bind with lower
multivalency, (e.g. the top panels in Fig. 4(e) and all panels in Fig. 4(f)), show diffuse-circular patterns.
The circular- and annulus-like localization profiles for a spherical NC denote two distinct states of NC
binding; the former is mediated primarily by ligands in the vicinity of the poles while the latter is medi-
ated by ligands in the vicinity of the equator. Using the method outlined previously [38, 48] we will later
show how such spatial patterns can be used to evaluate the loss of translational entropy of bound recep-
tors on the substrate. It should also be noted that the annulus-like pattern had previously been observed
in the synapse of T-cells with their receptors [102].
Next we analyze the energy landscape for NC binding by explicitly computing the potential of mean
force (PMF) WNC as described in the methods section, also see [38, 48]. WNC is a measure of the
enthalpic contribution to binding and it is related to the binding efficacy through the T4 term in Eqn. (9).
For systems with low multivalency (where the T1, T2 and T3 ∼ 1.0), WNC may be used as a direct
readout for the efficacy of the NC multivalent binding. The PMF profile for the SB, IB and WB systems
are shown in Figs. 4(g), (h) and (i), respectively. It should be noted that in our modelWNC is non-zero
only when the average multivalency 〈m〉 > 0. This feature is explicitly seen for the case of Keffb =1 N/m
in Fig. 4(i) whereWNC(z) = 0 for all values of z.
For the SB system, displayed in Fig. 4(g), WNC shows a very strong dependence on Keffb . A com-
parison of the PMF profiles for the SB system shows: (i) for stiffer springs (Keffb =1.0 and 10−1 N/m),
the binding energy landscape is highly complex and contains a number of distinct energy wells; each of
these wells denote distinct multivalent states of the NC, (ii) as Keffb decreases (e.g. for 10−2 and 10−3
N/m) the distinct energy wells overlap resulting in a smooth energy landscape (iii) the PMF well depth
is a strong function of Keffb and shows a non-linear increase with decreasing Keffb . The increase in well
depth observed in our studies points to the fact that Keffb can be used a tunable parameter in the design
of functionalized nanocarriers; this can be modulated by attaching the ligand to the NC via tethers of
different molecular weight and stiffness. The PMFs for the IB system shown in Fig. 4(h) also displays
the various features noted for the SB system except that they do not contain any of the rugged free energy
landscapes seen at higher values ofKeffb . This may be attributed to the weak binding interactions between
the NC and the receptors, as is evidenced by the nearly zero multivalency profile shown in Fig. 4(b).
We also observe that for all values of Keffb , the PMF well depth for the IB system is smaller compared
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to that for the SB; e.g. for Keffb = 10−3 N/m, we observe a well depth of −155 kBT and −340 kBT
for the IB and SB systems, respectively. However these trends do not hold for the WB system shown in
Fig. 4(h). Here, we findWNC to be weakly sensitive to changes in Keffb since the binding energy (∼ −1.8
kBT ) is indistinguishable from thermal noise. The distinct energy wells seen in some of the PMF curves,
for the WB and SB systems, have a depth of ∼1 kBT and hence are not statistically significant. These
results indicate that when ∆Hb is small, the effective spring constant for a receptor-ligand interaction is
an insensitive parameter, one that does not benefit from tuning.
The enthalpic measures of the free energyWNC depicted in Figs. 4(g)–(i) do not tell the whole story
because there is significant enthalpy-entropy compensation in these systems. That is, a gain in T4 due to
multivalent binding with large 〈m〉 also leads to a loss in the configurational entropies which can offset
each other. We discuss the entropies next by computing the terms T1–T3 in eqn. (9) for the data shown
in Fig. 4. The multivalency and the various losses in receptor translational, receptor flexural, and NC
rotational entropies T1, T2 and T3 are shown in Fig. 5, as a function of the effective spring constant Keffb .
The average multivalency 〈m〉 for each of the three systems shown in Fig. 5(a) was directly computed
from the umbrella sampling trajectories and in this calculation we weighted the statistics of each window
with its corresponding Boltzmann factor exp(−βWNC). The values of 〈m〉 computed using this tech-
nique agrees very well with that shown in Figs. 4 (a), (b) and (c) which were directly computed using
equilibrium simulations. This agreement establishes the consistency between the umbrella sampling and
the equilibrium simulations in terms of the accessed configurational space and establishes the ergodic-
ity of the system under the conditions explored. As before, for the SB and IB systems we find 〈m〉 to
decrease with increasing Keffb , while for the WB system we find 〈m〉 ∼ 0 for all values of Keffb .
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Figure 5: (a) The average multivalency, 〈m〉, and the various loss in entropies, (b) T1, (c) T2 and (e) T3,
are shown as a function of the effective spring constant Keffb . The terms T1, T2 and T3 are dimension-
less. Panel (d) shows the distribution of the receptor flexure angle θr both in the bound (solid line) and
unbound (dashed line) states. The shaded regions denote the corresponding areas used to calculate T2.
Translational entropies of the bound and unbound receptors: The T1 term in Eqn. (9) for the SB,
IB and WB systems are shown in Fig. 5(b). In computing T1, we took the unbound receptor area to be
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∫
u
dx1dy1 = L
2
s/Nr, as described in our discussions on Eqn. (9), and computed the area of the bound
receptor
∫
b
dx1dy1 directly from the localization profiles shown in Figs. 4(d), (e) and (f); here for each
system, the total area of the dark regions was taken to be 〈m〉(∫
b
dx1dy1). For the WB system, we find
T1 ∼ 1.0 for all values of Keffb and this is consistent with the observation in Fig. 5(a), where 〈m〉 ∼ 0 for
all cases of the WB system. On the other hand, for the SB system we observe T1 ∼ 0.25 for all values of
the spring constant reflecting the fact that the higher multivalencies (Fig. 5(a)) and the stronger binding
free energies (Fig. 4(g)) seen for the SB system severely constrain the accessible degrees of freedom for
a bound receptor. For the IB system, we find T1 ∼ 0.5 for Keffb ≤ 10−2 N/m and T1 ∼ 0.0 for higher
spring constants and this is a signature of a transition from a bound to an unbound regime. The large error
bars seen for Keffb ≤ 10−1 N/m is due to the occasional transition of the NC between its small number of
bound and large number of unbound states and this is consistent with the multivalency distribution and
localization profile shown in Figs. 4(b) and (e), respectively. It is evident from Eqn. (9) that a reduction
in the value of T1 also reduces the equilibrium association constant Ka but the magnitude by which T1
influences Ka varies from system to system; e.g., for the SB system with T1 = 0.25 and 〈m〉 = 10, the
expected reduction inKa due to loss in receptor translational entropy is (0.25)10 ∼ 10−6, while for the IB
system with T1 = 0.5 and similar multivalency the expected reduction is (0.5)10 ∼ 10−3. This is a gen-
eral phenomenon that is valid for all configurational entropy terms and quantifies the enthalpy-entropy
compensation in these multivalent systems.
Flexural entropies of the bound and unbound receptors: The T2 term was computed from the prob-
ability distribution of θr, the polar angle of the receptor, which for the bound and unbound states are
shown in Fig. 5(d) as solid and dashed lines, respectively. The unbound distribution, as expected from
(1), follows the Boltzmann statistics exp(−βHflex), with a peak value at θr = 0. On the other hand, the
peak value for the bound receptors shifts to θr ∼ 0.03 thereby constraining the flexural degrees of free-
dom. The bound and unbound state integrals in the T2 term were taken to be the numerically computed
areas under the solid and dashed curves, respectively. In Fig. 5(c) we display the T2 term in Eqn. (9) as
a function of Keffb for the SB, IB and WB systems. We find T2 ∼ 1.0 for all the three systems which
indicates that not only the flexural degrees of freedom do not incur any entropy loss upon multivalent
NC binding, but also that the receptor flexural degrees of freedom are not severely impacted by changes
in ∆Hb and Keffb . However, there is a noticeable increase in receptor flexure for Keffb > 0.1 which is
reflected in the large error bars seen in this regime. The increase in the fluctuations of the receptor flexure
is a signature of flexural contributions to multivalent binding. In other words, since the cutoff distance
for bond formation d∗ is extremely small when Keffb > 0.1 (0.3 and 1.5 nm for the SB and IB systems)
the receptors promote binding within this small cutoff distance by accessing more flexural degrees of
freedom.
Rotational entropies of the NC: We estimated the rotational volume (σφpσcos θpσψp) of a bound NC
from the fluctuations of its Euler angles about the NC center of mass, as described in the methods section
and in Eqn. (9), also see Suppl. Info., Sec. S5. The computed values of the T3 term are displayed in
Fig. 5(e) for the SB, IB and WB systems. The T3 term clearly delineates the bound state of the NC from
its unbound state, with T3 < 1.0 for the former and T3 ∼ 1.0 for the latter. T3 for the WB system show
a clear transition from a bound state to an unbound state at Keffb > 10−2 N/m. On the other hand, T3 for
the SB and WB systems shows a monotonous decrease with increasing spring constant. The observed
decrease in the rotational entropy at larger values of Keffb is due to the extremely small values of d∗ that
constrains the rotational degrees of freedom accessible to a bound NC. T3 for the IB system shows an
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increasing trend at Keffb > 100 N/m and this is due to constant binding and unbinding of the NC, as noted
previously in our discussion regarding the multivalency under these conditions. Though the rotational
entropy for a bound NC shows a large decrease from its unbound value, its contribution to Ka is not as
significant as that of T1 and T2 (unless the multivalency 〈m〉 ∼ 1), since the T3 term does not depend on
the multivalency, see Eqn. (9).
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Figure 6: The configurational entropies T1–T3, shown in Fig. 5, and the enthalpic term T4 =∫
exp(−βWNC)dz as a function of the average equilibrium multivalency 〈m〉. The log values of T4
are displayed and these were computed using PMF profiles shown in Figs. 4(g), (h) and (i). In all pan-
els, circle, square and triangle represent SB, IB and WB systems, respectively, while the various colors
denote different values of Keffb = 100, 10−1, 10−2, 10−3 N/m.
4.4 Scaling behavior of the configurational entropies as a function of multivalency:
In Figs. 6(a)–(c) we display the three configurational entropies T1–T3 as function of their respective
average multivalency 〈m〉. T2 in Fig. 6(b) is insensitive to changes in 〈m〉, while the values of T1 and
T3 follow a peaked distribution when in the bound state; here, we define a bound state to be one in
which Ti ≤ 0.5. The bound state values of T1 and T3 were fit to an exponentially modified Gaussian
distribution which are as dotted lines in Figs. 6(a) and (c).
We next quantify the T4 term in Eqn. (9) which represents the enthalpic contribution to binding. In
Fig. 6(d), we display T4 as a function of the average multivalency 〈m〉, for the SB, IB and WB systems.
The different values of 〈m〉 correspond to simulations with varying values of Keffb and this correspon-
dence was previously shown in Fig. 5(a). For the WB system we find log10T4 ∼ 0 and this is expected
since 〈m〉 ∼ 0 in all our simulations of the WB system. As expected, for the SB and IB systems log10T4
shows a linear increase with increasing 〈m〉 for the most part, i.e. except for SB with a low Keffb = 10−3
N/m. It is interesting to note that all values of T4 computed for entirely different systems appear to fol-
low this scaling relation that only depends on 〈m〉, i.e., kBT log10 T4 = C〈m〉, with a value of C = 3.9
kBT . Later, we will show that this scaling is universal and even applies to different ligand compositions
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(Sec. 4.6) and different sized NCs (Sec. 4.7). We ascertain the following by comparing the magnitudes
of T4 to the various configurational entropies T1, T2 and T3, see Figs. 6(a)–(d): (i) for very small and
very large values of 〈m〉, the enthalpic contribution T4 is the major determinant of the NC association
constant Ka, and (ii) at intermediate values, e.g., for the SB with 〈m〉 ∼ 10 for which we previously cal-
culated (T1)〈m〉 ∼ 10−6, the magnitudes of the entropic and enthalpic terms are comparable and hence
Ka is jointly determined by both these contributions. The scaling relations in Eqn. (9) and the plots in
Figs. 6(a)–(d) together quantify the enthalpy-entropy compensation discussed earlier.
4.5 Effect of particle shape anisotropy on NC binding
In the previous section, we had shown that the nature of the molecular interactions of a receptor-ligand
pair can significantly influence the binding efficacy of a functionalized particle at the mesoscale. Here we
investigate how the shape of the functionalized particle is a key factor that determines the binding efficacy
of a functionalized nanocarrier. In the remainder of this article, we will primarily use the multivalency
〈m〉 and the T4 term to qualitatively determine the changes in the efficacy of binding as a function of the
various system parameters.
We assess the role of particle anisotropy on NC binding by analyzing its multivalency for seven differ-
ent spheroidal particles with aspect ratios ε =0.1, 0.2, 0.5, 1.0, 2.0, 5.0 and 10.0. The different particles
were chosen to have similar volumes (equal to that for a spherical particle with a = b = c = 50 nm), simi-
lar number of ligandsNab = 162, and binding to a substrate with receptor density of 2000 receptors/µm2;
the exact dimensions used in our simulations are given in Suppl. Info., Sec. S3. Since computing PMF
profiles for anisotropic particles is non-trivial, we primarily rely on the statistics of its multivalency to
qualitatively characterize their binding efficacies. As previously shown in Fig. 6, we associate particle
shapes that have a higher multivalency to a higher binding avidity. The multivalency distribution as a
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Figure 7: Multivalency distribution P (m) as a function of the particle aspect ratio ε. Data shown for (a)
the SB system and (b) the IB system, with Nab = 162, Nant = 2000 and ε =0.1, 0.2, 0.5, 1.0, 2.0, 5.0
and 10.0. Panel (c) shows representative snapshots of the bound state of SB ellipsoidal NCs with ε =0.1,
1.0 and 10.0 — the unbound ligands have been removed for clarity and the shaded region shows a cross
section of the NC.
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function of ε for the SB and IB systems with Keffb = 0.1 N/m is displayed in Figs. 7(a) and (b), respec-
tively; additional data forKeffb = 1.0 may be found in the Suppl. Info., Sec. S6. P (m) for ε = 1.0 (shown
earlier in Fig. 4(a) and (b)) is used as the reference to assess the effect of particle shape anisotropy. For
the SB, see Fig. 7(a), we find the multivalency of ellipsoidal particles, both ε < 1.0 and ε > 1.0, to be
larger compared to that for ε = 1.0. The oblate spheroids specifically show a higher efficacy for binding
and this is exemplified in Fig. 7(a) for ε = 0.2 and 0.1. The role of shape anisotropy is more pronounced
for the IB system shown in Fig. 7(b). Here, the particle is primarily in an unbound state for aspect ratios
0.2 ≤ ε ≤ 5.0. This may be inferred from the dominant contribution of P (m = 0) for these values of
ε. A further change in the particle aspect ratio, either to more oblate, (see Fig. 7(a) for ε = 0.1), or to
more prolate, (see Fig. 7(a) for ε = 10.0), increases the avidity of NC binding by stabilizing non-zero
multivalent interactions. Our results clearly show that the shape of the ligand-coated-particle can be a key
factor that determines NC efficacy, particularly when the functionalized ligand has a weak affinity for the
target receptor. We also find that the oblate spheroids display a higher efficacy for binding compared to
spherical and prolate-spheroidal particles.
4.6 Effect of ligand heterogeneity
The binding efficacy of a functionalized NC also depends on the composition of ligands. This is a com-
mon scenario even when the NC is functionalized with only one type of ligand, usually SB, because
of the phenomenon of opsonization [66, 67, 81]. Here, proteins or epitope-fragments from the serum or
plasma can deposit onto the NC surface to represent a second class of ligands that are typically IB or WB.
We assessed the role of ligand heterogeneity on binding efficacy by studying the binding of a spherical
NC, with a = b = c = 50 nm functionalized with two types of ligands, chosen to be the SB and IB
systems. The ligands were randomly distributed on the particle surface and both types of ligands were
taken to bind to the same surface receptor with corresponding values of ∆Hb, as in Table 1, and with a
spring constant Keffb = 1.0 N/m. All our results correspond to the average behavior determined from four
independent ensembles. We systematically varied the composition of SB:IB ligands, holding constant the
total number of ligands Nl = 162. In Fig. 8, we show the computed values of the PMF,WNC, the average
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Figure 8: The potential of mean force for a spherical nanocarrier, with a = b = c = 50 nm, functional-
ized with varying concentrations of the SB and IB receptors. The average multivalency 〈m〉 and the T4
term computed from the PMF are shown in panels (b) and (c), respectively. Data shown for a NC with
a = b = c = 50 nm with Keffb = 1.0 N/m.
multivalency, 〈m〉, and the enthalpic contribution to binding, T4. The corresponding data are displayed
in panels (a), (b) and (c) respectively.WNC is highly sensitive to changes in the ligand composition and
we find its well depth increases with increasing composition of SB ligands, as shown in Fig. 8(a). The
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observed sensitivity is also seen in the T4 term shown in Fig. 8(c) whose values are in the range 105
for the fully IB system (0.0:1.0) to 1015 for the fully SB system (1.0:0.0). The corresponding changes in
the T1, T2 and T3 terms are not significant and this is shown in Suppl. Info., Sec. S7. The observed ten
orders of magnitude increase in T4 is achieved with no considerable changes in the average multivalency,
which as shown in Fig. 8(b) is 〈m〉 ∼ 3 for the five ligand compositions investigated here. Moreover,
the values of T4 in Fig. 8(c) show a gradual increase in response to changes in the ligand composition,
unlike those in Fig. 6 that show a highly non-linear increase in response to changes in ∆Hb and Keffb .
Thus, these results clearly demonstrate that the ligand composition can be used as a tunable parameter to
design NCs with a wide range of binding efficacies and also can be pre-engineered to reduce the effect of
opsonization that occurs in vivo. The role of ligand heterogeneity as a control parameter for NC uptake
was recently demonstrated in an experimental study by Levine and Kokkoli [103], for the case of NCs
coated with ligands for α5β1 and α6β4 integrins.
4.7 Effect of particle size on binding
Specific binding through multivalent receptor-ligand interactions is effectively used by systems of vary-
ing sizes from a viral particle to a cell. The size of the particle influences a multitude of factors including
changes in the number of ligands, reduction in the particle curvature, all of which can influence particle
binding. We systematically studied this phenomenon using solid spherical particles of five different sizes
a = 50, 150, 250, 350 and 500 nm, with a = b = c. The total number of ligands on the particles were
chosen to be Nl = 162, 1458, 4050, 7938 and 16200, respectively, such that all particles have a uniform
ligand density of 14%. All our calculations were performed using the SB system for two different spring
constants Keffb = 0.1 and 1.0 N/m. In Fig. 9(a), we showWNC as a function of the scaled particle separa-
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Figure 9: The effect of size on the binding affinity of a functionalized particle. (a) Comparison of the
potential of mean forceWNC for five different spherical particles with a=50, 150, 250, 350 and 500 nm.
Data shown for the SB system with Keffb = 0.1 N/m. (b) The average equilibrium multivalency 〈m〉 is
shown as a function of a while its quadratic dependence on a is shown as solid and dotted lines for the
two spring constants. (c) The computed values of T4 are plotted as a function of 〈m〉 and the solid band
represents the relation kBT log10 T4 ∼ C〈m〉, with C ∼ 3.9 kBT . The filled and open symbols in panels
(b) and (c) correspond to Keffb = 0.1 and 1.0 N/m, respectively.
tion z − a for Keffb = 0.1 N/m (data for Keffb = 1.0 N/m may be found in the Suppl. Info., Sec. S8). We
find the depth of WNC to increase with increasing a and this effect is more pronounced for Keffb = 0.1
N/m. The well defined minimum seen at (z − a) ∼ 30 nm for particles with 50 ≤ a ≤ 350 nm shows
that there is a significant energy barrier for the bound particle to move towards the substrate. However,
this barrier seems to be absent for the 500 nm particle for which WNC decreases as the particle moves
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towards the substrate. This is consistent with our observation that the equilibrium multivalency for the
500 nm particle also shows a huge increase, as expected for a particle very close to the substrate. The
average multivalency 〈m〉 for Keffb = 0.1 and 1.0 N/m are shown in Fig. 9(b) as filled and open symbols,
respectively. 〈m〉 increases with particle size and the largest value of 〈m〉 ∼ 80 is seen for the 500 nm
particle with Keffb = 0.1 N/m. The observed increase in 〈m〉 as a function of a can be fully attributed
to the corresponding increase in the total number of ligands that scales as Nl ∝ a2. If 〈m〉 increases
primarily due to an increase in the number of ligands that contribute to binding we expect 〈m〉 ∝ a2.
The computed values of 〈m〉 are in excellent agreement with this relation as shown in Fig. 9(b) where
the dashed and solid lines are the best fit parabolic curves for Keffb = 0.1 and 1.0 N/m, respectively.
In Fig. 9(c), we plot T4 as a function of 〈m〉 for different particle sizes and spring constants. The filled
and open symbols correspond to data for Keffb = 0.1 and 1.0 N/m, respectively. Intriguingly, the data col-
lapses onto the same scaling relation, kBT log10 T4 = C〈m〉 with C = 3.9 kBT , as shown in Sec. 4.4.
The observed scaling relation has a direct and simple interpretation, that the total binding free energy of
the particle is 〈m〉C and the equilibrium bound state of each of the 〈m〉 multivalent bonds correspond to
an average energy C.
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Figure 10: The enthalpic contribution T4 for functionalized spherical particles is plotted as a function
of the average multivalency 〈m〉. The different sets of data were taken from Figs. 6, 8 and 9. The solid
diagonal band represents the scaling relation kBT log10 T4 = C〈m〉, with C ∼ 3.9 kBT . The inset shows
the validity of the scaling behavior for average multivalencies in the range 0 < 〈m〉 < 15.
We have presented a multiscale computational framework to study the multivalent adhesion of a rigid
ligand-coated particle adhering to receptors on a substrate. In our approach, the molecular nature of
receptor-ligand interactions has been retained by carrying out molecular dynamics simulations of mono-
valent receptor-ligand interactions. The results of the molecular dynamics simulations were directly used
to parameterize the coarse-grained potentials. Our results show that the binding avidity of nano-sized
functionalized carriers is primarily determined by the dominant enthalpy-entropy compensation seen in
these systems. We have demonstrated this feature by explicitly computing the free energy for multivalent
binding and also the losses in configurational entropies T1, T2 and T3 associated with the configurational
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variables for receptor diffusion, receptor flexure, and rotational motion of the nanocarrier, respectively.
Of these, T1 is the most dominant entropic term, particularly for systems with large number of multivalent
interactions 〈m〉, since losses in T1 penalizes the binding avidity as T1〈m〉. The effect of particle shape
anisotropy on NC binding was shown to promote higher multivalency (〈m〉) for both prolate and oblate
particles, compared to their spherical counterpart. Moreover, we have shown that the ligand composition,
substrate compliance, tether elasticity and particle size can also be used as tunable design parameters to
modulate the overall binding avidity of the NC.
Our study suggests that each of the entropic and enthalpic terms that govern the binding avidity of the
functionalized particle may follow an universal scaling behavior that only depends on the multivalency
of the particle in its bound state. For instance, in Fig. 10 we show this feature for the enthalpic contribu-
tion T4 computed for spherical particle under completely different conditions; i.e., the three sets of data
corresponding to: (i) analysis of the effect of ∆Hb and Keffb (Fig. 6), (ii) the effect of ligand composition
(Fig. 8), and (iii) the effect of particle size (Fig. 9). T4 for all these system fall on a universal master
curve kBT log10 T4 = C〈m〉, as discussed earlier, with a single value of C ∼ 3.9 kBT . The presence
of such an universal scaling is surprising and would imply that we can describe the thermodynamics of
binding merely by computing the multivalency of the particle. This is a welcome finding as it would sig-
nificantly reduce the computational efforts required to estimate the binding avidity; i.e., the multivalency
can simply be obtained using one equilibrium simulation rather than resorting to the umbrella sampling
necessary for computing the entire free energy landscape. Whether all types of functionalized particles,
independent of their shape, size and ligand heterogeneity, follow this scaling behavior and hence making
it truly universal is to established and still remains an open question. A closer look at the inset to Fig. 10
shows that some values of T4, particularly those from Fig. 9, show deviations larger than one standard
deviation (but agree to within 2 standard deviations) from the proposed scaling relation and these out-
liers corresponds to NCs with sizes in the range 150 – 350 nm. The observed deviations are attributed
to not being able to define a characteristic multivalency that represents the average behaviour because
of the degeneracy in the equilibrium multivalency distributions. This is displayed in the Suppl. Info.,
Suppl. Info., Sec. S9, where the multivalency distribution for particles that adhere to the scaling relation
(for a = 50 and 500 nm) are unimodal, while those for particles that deviate from the scaling relation
(a = 150 – 350 nm) are multimodal. The presence of degenerate states leads to broad multivalency distri-
butions and hence a deviation from the scaling relation, which is plotted using the average multivalency
〈m〉.
Despite the large advances in the design of functionalized nanocarriers, the development of highly
efficient and robust targeted delivery systems still remains a challenge. This is commonly attributed due
to our rudimentary understanding of complex factors such as physiological conditions, cell heterogeneity,
tissue architecture and target chemistry [3, 4]. Therefore, it is essential to develop quantitative models for
nanocarrier dynamics and adhesion in its natural environment that can help comprehend these inherent
complexities. The work presented in this article should be viewed as a step in this direction. In our current
model, while the entropy calculations are extensive, the treatment based on bell bond [104] and soften-
ing of spring due to membrane is simplistic in some scenarios like the IB system. More complex bonds
like catch bonds, entropy of membrane, etc. can be added to our framework by following and incorpo-
rating models published in the literature [21, 28, 48, 105]. Atomistic simulations can be used to further
refine these models and include biochemical specificity [59, 98]. Despite the minimalistic nature of our
model, it has helped us gain some key insights into the role and magnitudes of configurational entropies
on NC binding which are non-trivial and non-intuitive, relative to the more intuitive (but nevertheless
hard-to-quantify) multivalent enthalpic contributions. It should be noted that the effect of configurational
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entropies is particularly pronounced for particle dimensions in the range 50–350 nm which is the pre-
ferred size for targeted carriers in most applications, making this study highly relevant for nanoparticle
design. Other complexities such a physiological and hydrodynamic barriers can be added to the design
in a modular fashion and integrated with the multivalent configurational entropy and enthalpy module
we have presented in this work in order to develop a general and flexible computational platform for the
design of functional nanocarriers for applications in nanomedicine.
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